References
- Arvand A, Bastians H, Welford SM, et al (1998). EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene, 17, 2039-45. https://doi.org/10.1038/sj.onc.1202129
- Asiaf A, Ahmad St, Fau - Aziz SA, et al (2014). Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir. Asian Pac J Cancer Prev, 15, 6397-403. https://doi.org/10.7314/APJCP.2014.15.15.6397
- Atefeh Seghatoleslam AZ (2009). Effects of over-expression of loc92912 gene on cell cycle progression. IJMS, 34, 277-84.
- Banerjee S, Brooks Ws Fau - Crawford DF, Crawford DF (2007). Inactivation of the ubiquitin conjugating enzyme UBE2Q2 causes a prophase arrest and enhanced apoptosis in response to microtubule inhibiting agents. Oncogene, 4, 6509-17.
- Bassermann F, Pagano M (2010). Dissecting the role of ubiquitylation in the DNA damage response checkpoint in G2. Cell Death Differ, 17, 78-85. https://doi.org/10.1038/cdd.2009.104
- Bremm A, Komander D (2011). Emerging roles for Lys11-linked polyubiquitin in cellular regulation. Trends Biochem Sci, 36, 355-63.
- Burger AM, Seth AK (2004). The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. Eur J Cancer, 40, 2217-29. https://doi.org/10.1016/j.ejca.2004.07.006
- Chang R, Wei L, Lu Y, et al (2014). Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma. J Mol Histol, 46, 45-56.
- Chen A, Kleiman FE, Manley JL, et al (2002). Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase. J Biol Chem, 277, 22085-92. https://doi.org/10.1074/jbc.M201252200
- Chen L, Madura K (2005). Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue. Cancer Res, 65, 5599-606. https://doi.org/10.1158/0008-5472.CAN-05-0201
- Cheng YW, Shawber C, Fau - Notterman D, et al (2006). Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay. Genome Res, 16, 282-9.
- Chuang SM, Chen L, Lambertson D, et al (2005). Proteasomemediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol Cell Biol, 25, 403-13. https://doi.org/10.1128/MCB.25.1.403-413.2005
- Dapas B, Tell G, Scaloni A, et al (2003). Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell line specifically binding to aptameric cytotoxic GT oligomers. Eur J Biochem, 270, 3251-62. https://doi.org/10.1046/j.1432-1033.2003.03713.x
- Ehrlich M (2002). DNA methylation in cancer: too much, but also too little. Oncogene, 12, 5400-13.
- Herman JG, Graff JR, Myohanen S, et al (1996). Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A, 93, 9821-6. https://doi.org/10.1073/pnas.93.18.9821
- Jones PA, Baylin SB (2007). The epigenomics of cancer. Cell, 128, 683-92. https://doi.org/10.1016/j.cell.2007.01.029
- Lamberti A, Caraglia M, Longo O, et al (2004). The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article. Amino Acids, 26, 443-8.
- Locker GY, Hamilton S, Harris J, et al (2006). ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol, 24, 5313-27. https://doi.org/10.1200/JCO.2006.08.2644
- Maeda H, Miyajima N, Fau - Kano S, et al (2009). Ubiquitinconjugating enzyme UBE2Q2 suppresses cell proliferation and is down-regulated in recurrent head and neck cancer. Mol Cancer Res, 7, 1553-62. https://doi.org/10.1158/1541-7786.MCR-08-0543
- Mokarram P, Naghibalhossaini F, Fau - Saberi Firoozi M, et al (2008). Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. World J Gastroentrol, 14, 3662-71. https://doi.org/10.3748/wjg.14.3662
- Nelson RL, Persky V, Turyk M (1999). Determination of factors responsible for the declining incidence of colorectal cancer. Dis Colon Rectum, 42, 741-52. https://doi.org/10.1007/BF02236929
- Nikseresht M, Seghatoleslam A, Fau - Monabati A, et al (2010). Overexpression of the novel human gene, UBE2Q2, in breast cancer. Cancer Genet Cytogenet, 197, 101-6. https://doi.org/10.1016/j.cancergencyto.2009.11.020
- Seghatoleslam A, Bozorg-Ghalati F, Monabati A, et al (2014). UBE2Q1, as a Down Regulated Gene in Pediatric Acute Lymphoblastic Leukemia. int j mol cell med, 3, 95-101.
- Seghatoleslam A, Monabati A, Fau - Bozorg-Ghalati F, et al (2012a). Expression of UBE2Q2, a putative member of the ubiquitin-conjugating enzyme family in pediatric acute lymphoblastic leukemia. Arch Iran Med, 15, 352-5.
- Seghatoleslam A, Nikseresht M, Fau - Shafiee SM, et al (2012b). Expression of the novel human gene, UBE2Q1, in breast tumors. Mol Biol Rep, 39.
- Seghatoleslam A, Zambrano A, Fau - Millon R, et al (2006). Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours. Biochem Biophys Acta, 6.
- Shafiee SM, Seghatoleslam A, Nikseresht M, et al (2013). UBE2Q1 expression in human colorectal tumors and cell lines. Mol Biol Rep, 40, 7045-51. https://doi.org/10.1007/s11033-013-2824-8
- Shafiee SM, Seghatoleslam A, Nikseresht M, et al (2014). Expression Status of UBE2Q2 in Colorectal Primary Tumors and Cell Lines. Iran J Med Sci, 39, 196-202.
- Shah R, Jones E, Vidart V, et al (2014). Biomarkers for early detection of colorectal cancer and polyps: systematic review. Cancer Epidemiol Biomarkers Prev, 23, 1712-28. https://doi.org/10.1158/1055-9965.EPI-14-0412
- Srivastava S, Shahi UP, Dibya A, et al (2014). Distribution of HPV genotypes and involvement of risk factors in cervical lesions and invasive cervical cancer: a study in an indian population. Int J Mol Cell Med, 3, 61-73.
- Suzuki H, Toyota M, Fau - Sato H, et al (2006). Roles and causes of abnormal DNA methylation in gastrointestinal cancers. Asian Pac J Cancer Prev, 7, 177-85.
- Urano T, Saito T, Tsukui T, et al (2002). Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature, 417, 871-5. https://doi.org/10.1038/nature00826
- van Wijk SJ, Timmers HT (2010). The family of ubiquitinconjugating enzymes (E2s): deciding between life and death of proteins. Faseb J, 24, 981-93. https://doi.org/10.1096/fj.09-136259
- Voutsadakis IA (2008). The ubiquitin-proteasome system in colorectal cancer. Biochem Biophys Acta, 1782, 800-8.
- Wajed SA, Laird PW, DeMeester TR (2001). DNA methylation: an alternative pathway to cancer. Ann Surg, 234, 10-20. https://doi.org/10.1097/00000658-200107000-00003
- Wan C, Chen J, Fau - Hu B, et al (2014). Downregulation of UBE2Q1 is associated with neuronal apoptosis in rat brain cortex following traumatic brain injury. J Neurosci Res, 92, 1-12. https://doi.org/10.1002/jnr.23305
- Weitz J, Koch M, Debus J, et al (2005). Colorectal cancer. Lancet, 365, 153-65. https://doi.org/10.1016/S0140-6736(05)17706-X
- Zhu S, Yao F, Fau - Li WH, et al (2013). PKC?-dependent activation of the ubiquitin proteasome system is responsible for high glucose-induced human breast cancer MCF-7 cell proliferation, migration and invasion. Asian Pac J Cancer Prev, 14.
Cited by
- Epigenetic biomarkers in colorectal cancer: premises and prospects pp.1366-5804, 2016, https://doi.org/10.1080/1354750X.2016.1252961